Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Zebrafish offers clue to alleviate gastrointestinal distress related to autism

Zebrafish offers clue to alleviate gastrointestinal distress related to autism

University of Miami researchers have discovered a clue in the humble zebrafish’s digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.

By replicating a mutation in zebrafish that causes a rare, autism-related genetic condition known as Phelan-McDermid Syndrome in humans, the researchers found a drastic reduction in the number of cells that produce serotonin in the mutant zebrafish’s gut. Perhaps better known as the body’s natural mood stabilizer, serotonin also initiates the contractions that move food through the digestive system.

Published last week in the journal Molecular Autism, the study is the first to show that a mutation of a particular autism-associated gene, SHANK3, causes food to move through the digestive tract at an abnormally slow pace. While the finding applies to zebrafish, a common freshwater aquarium species that shares about 70 percent of its genes with humans, it could explain why many people with an autism spectrum disorder, and particularly those with Phelan-McDermid Syndrome (PMS), often suffer severe and disruptive bouts of constipation, diarrhea, reflux, and/or cyclical vomiting.

More importantly, it could open the door to treatments that alleviate such unpleasant gastrointestinal, or GI, symptoms.

“The fact that we see reduced motility in the GI tract of fish with shank3 mutations is likely explained by the absence of these serotonin-producing cells, and that suggests that if we could find a way to increase motility we might be able to help with the GI problem,” said senior author Julia Dallman, associate professor of biology whose UM lab studies inherited nervous system disorders by modeling them in zebrafish. “One issue in autism right now is that a lot of the drugs given to kids with autism to address their behavioral issues actually make their gut function worse. So by having a model of gut function we can try to find treatments that don’t make it worse.”

Dallman and two of her graduate students, David M. James and Robert A. Kozol, the first co-authors of the study, began earnestly modeling GI distress in zebrafish after they were invited to the 2016 biennial meeting of the international Phelan-McDermid Syndrome Foundation in Orlando. There they heard firsthand accounts from parents of children born with PMS which, caused by a deletion or mutation of the SHANK3 gene at the end of chromosome 22, is characterized by moderate to severe intellectual disabilities and developmental delays, absent or delayed speech, decreased muscle tone, and epileptic seizures.

Yet, despite all those very daunting challenges, parents often expressed deep frustration over their child’s GI issues, which affected their quality of life on a daily basis, often making ordinary routines and milestones, like eating and toilet-training, exceedingly difficult.

“At that time, there hadn’t been much published about GI issues in our community, but when you listen to parents they would always talk about how troubling it was,” said Geraldine Bliss, past chair of the foundation’s research support committee.”There was a whole constellation of issues–sometimes diarrhea, sometimes constipation, sometimes alternating diarrhea and constipation, reflux–all kinds of GI problems, but it hadn’t really been characterized or reported in the literature.”

Now, the common zebrafish and James’ interest in characterizing GI issues in autism seem destined to help shed light on the confounding problem.

About an inch long at maturity, the zebrafish is a valuable model for human disease because, aside from having a similar genetic structure to humans, it develops rapidly and, until its second week of life, is almost completely transparent. That’s when it begins developing the telltale dark stripes for which it is named.

That early transparency, coupled with an apparent zeal for what juveniles consider yummy food, enabled James and Kozol to record what happens when zebrafish lacking the shank3 gene digested chicken egg yolks, which were infused with tiny, florescent-green tracking beads. The films clearly showed that the mutant fish not only had slower and less frequent gut contractions than normal zebrafish, but that the ingested food particles got stuck in the junction between the stomach and the intestine for prolonged periods of time.

The reason came as a surprise. Initially, the researchers hypothesized the shank3 mutation somehow damaged the fish’s enteric nervous system–the “brain” that controls the gut–but that was perfectly normal. Instead, the researchers found the shank3 mutants had drastically fewer serotonin-producing cells than their wild-type counterparts.

“It was definitely an ‘Aha!’ moment,” James said. “It opens up a lot, in terms of studying potential mechanisms for how all this dysmotility is occurring. If we can figure that out, we can start talking about what the proper treatments are, and what’s going to fix this–that’s the real question.”

The answer may lie in the distant future, but this first crucial step in unraveling a biological reason for autism-related GI distress is heartening to members of the PMS foundation, which began as a family support group in 1998, when 20 of the 23 families then known to be affected by a deletion or mutation of chromosome 22 first met.

Today, nearly 200 affected families from around the world attend the foundation’s meetings, the last of which was held in Texas last summer. That’s when James presented UM’s research on intestinal dysmotility in zebrafish, which not only won the conference’s research award but gave parents like Gail Fenton hope for a better future for their children.

“Joanna’s tummy troubles have been a major source of family stress for 15 years,” Fenton wrote from Australia about her 36-year-old daughter. “She is often hunched over because of tummy pain. She cries, even yells, when her tummy is sore. She’ll always have Phelan-McDermid Syndrome but her life, and the lives of fellow sufferers with these complex GI issues, would be so much happier without these negatives and we are so very thankful for the research that can lead to any helpful interventions.”

The study, Intestinal dysmotility in a zebrafish (Danio rerio) shank3a;shank3b mutant model of autism, was supported by grants from the National Institutes of Health’s National Institute of Mental Health and Eunice Kennedy Shriver National Institute for Child Health and Human Development. In addition to Dallman, James, and Kozol, the coauthors include Yuji Kajiwara, of the Seaver Autism Center for Research and Treatmentat the Icahn School of Medicine at Mount Sinai, New York; Adam L. Wahl and Emily C. Storrs, UM undergraduates; Joseph D. Buxbaum, also of the Seaver Autism Center; Mason Klein, associate professor in UM’s Department of Physics; and Baharak Moshiree, of the University of North Carolina’s Division of Gastroenterology.

Source:

https://news.miami.edu/stories/2019/02/see-through-fish-aid-scientists-in-autism-related-breakthrough.html

Tagged with:

About author

Related Articles